Spots Global Cancer Trial Database for cancer of prostate
Every month we try and update this database with for cancer of prostate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Far Infrared Radiation Treatment for Prostate Cancer | NCT00573820 | Prostatic Neopl... | Far Infrared Ra... | - | GAAD Medical Research Institute Inc. | |
| Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer | NCT00941915 | Prostate Cancer | SBRT Prostate | 40 Years - 82 Years | Duke University | |
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy | NCT05361798 | Cancer Of Prost... | M9241 Stereotactic Bo... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA | NCT04319783 | Advanced Prosta... Cancer of Prost... PSA Castrate Resist... | Darolutamide Radiotherapy | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 | NCT02362464 | Prostatic Neopl... Neoplasms of Pr... Prostate Cancer Cancer Of Prost... Stage D0 Prosta... | Multi-epitope (... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC | NCT05191017 | Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration Resi... Castration Resi... | NUV-422 Enzalutamide | 18 Years - | Nuvation Bio Inc. | |
| A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer | NCT00220194 | Cancer of Prost... | leuprolide acet... | 18 Years - | San Bernardino Urological Associates Medical Group Inc | |
| A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer | NCT03450109 | Cancer of Prost... | LY01005 Zoladex | 18 Years - | Luye Pharma Group Ltd. | |
| Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer | NCT04887935 | Prostate Cancer Cancer of Prost... | Dapagliflozin BIOSENSE Meter | 18 Years - | Washington University School of Medicine | |
| Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients | NCT02614859 | Cancer of Prost... | Observation and... Metformin and B... | 18 Years - | Fox Chase Cancer Center | |
| Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy | NCT03388619 | Cancer Of Prost... Prostate Neopla... Prostate Cancer Neoplasms of Pr... Prostatic Cance... | Prostate bed wi... Prostate bed ir... Whole Body Bone... 18F-NaF PET Ima... CT mpMRI ADT | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP | NCT03899077 | Cancer of Prost... | Apalutamide Leuprorelin Ace... Goserelin Aceta... Triptorelin Pam... Degarelix aceta... | 18 Years - | Cancer Research Antwerp | |
| Positioning and Tracking the Prostate During External Beam Radiation | NCT00123838 | Prostate Cancer | Calypso® 4D Loc... | 18 Years - | Varian, a Siemens Healthineers Company | |
| Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors | NCT02957357 | Cancer of Prost... Cancer of the P... Prostate Cancer Prostatic Cance... | - | Alliance Foundation Trials, LLC. | ||
| Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC | NCT05191017 | Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration Resi... Castration Resi... | NUV-422 Enzalutamide | 18 Years - | Nuvation Bio Inc. | |
| North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) | NCT02564120 | Cancer of Prost... Cancer of the P... Prostate Cancer Prostatic Cance... | 35 Years - 80 Years | UNC Lineberger Comprehensive Cancer Center | ||
| 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer | NCT03181867 | Prostate Neopla... Prostatic Cance... Prostate Cancer Cancer Of Prost... Metastatic Pros... | 18F-DCFPyL 18F-FDG PSMA-11 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer | NCT00134706 | Prostate Cancer | Docetaxel Carboplatin | 18 Years - | Dana-Farber Cancer Institute | |
| A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy | NCT00257478 | Prostate Cancer Cancer of Prost... Prostatic Cance... Cancer of the P... | YM155 | 18 Years - | Astellas Pharma Inc | |
| Real-time Motion Management During Prostate and Lung Radiotherapy | NCT05844761 | Cancer of Lung Lung Metastasis Cancer of Prost... | Triggered imagi... Synchrony MLC t... Synchrony MLC t... | 18 Years - | Region Skane | |
| A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors | NCT05214937 | Sedentary Behav... Cancer of Prost... | Intervention FitBit Only | 18 Years - | University of Toronto | |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer | NCT00970203 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | androgen ablati... DC1 vaccine | 18 Years - | Roswell Park Cancer Institute | |
| Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy | NCT03442075 | Cancer of Prost... | 18 Years - 75 Years | Instituto Mexicano del Seguro Social | ||
| Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy | NCT03442075 | Cancer of Prost... | 18 Years - 75 Years | Instituto Mexicano del Seguro Social | ||
| Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci | NCT01639859 | Cancer of Prost... | Elastography | 18 Years - | Hospices Civils de Lyon | |
| De-implementation of Low Value Castration for Men With Prostate Cancer | NCT03579680 | Cancer of Prost... | ADT ORDER CHECK... PROVIDER SCRIPT... | - | University of Michigan | |
| Sipuleucel-T Manufacturing Demonstration Study | NCT01477749 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | sipuleucel-T | 18 Years - | Dendreon | |
| Real-time Motion Management During Prostate and Lung Radiotherapy | NCT05844761 | Cancer of Lung Lung Metastasis Cancer of Prost... | Triggered imagi... Synchrony MLC t... Synchrony MLC t... | 18 Years - | Region Skane | |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) | NCT03896958 | Cancer, All Typ... Cancer of Liver Cancer of Stoma... Cancer of Head ... Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Colon Cancer Skin Cancer of Cervi... Cancer, Metasta... Cancer of Laryn... Cancer of Neck Cancer of Lung Cancer of Brain... Cancer of Vulva... Cancer of Pancr... Sarcoma GIST Small-cell Lung... Adenocarcinoma ... Cancer of Prost... Cancer, Advance... Adrenal Cancer Testicular Canc... Uterine Cancer Bronchoalveolar... Cancer Unknown ... Glioblastoma Mu... Oligodendroglio... Breast Cancer Renal Cell Carc... Hepatocellular ... Cholangiocarcin... Squamous Cell C... Transitional Ce... Cancer, Other Cancer, Anal Melanoma Cancer, Bile Du... Cancer, Bladder Cancer Cords Vo... Cancers Cell Ne... Cancer Differen... Cancer, Anaplas... | 1 Month - 99 Years | SpeciCare | ||
| Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | NCT04541225 | Glioma Glioma, Maligna... Glioma, Mixed Glial Cell Tumo... Breast Cancer Breast Carcinom... Cancer of Breas... Cancer of the B... Breast Tumor Malignant Tumor... Advanced Breast... Advanced Breast... Metastatic Brea... Metastatic Brea... Prostate Cancer Prostatic Cance... Cancer of Prost... Cancer of the P... Prostate Neopla... Castrate Resist... Castration-resi... Castration Resi... Glioblastoma Recurrent Gliob... | NUV-422 | 18 Years - | Nuvation Bio Inc. | |
| Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer | NCT04887935 | Prostate Cancer Cancer of Prost... | Dapagliflozin BIOSENSE Meter | 18 Years - | Washington University School of Medicine | |
| Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer | NCT00970203 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | androgen ablati... DC1 vaccine | 18 Years - | Roswell Park Cancer Institute | |
| North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) | NCT02564120 | Cancer of Prost... Cancer of the P... Prostate Cancer Prostatic Cance... | 35 Years - 80 Years | UNC Lineberger Comprehensive Cancer Center | ||
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) | NCT03896958 | Cancer, All Typ... Cancer of Liver Cancer of Stoma... Cancer of Head ... Cancer of Rectu... Cancer of Kidne... Cancer of Esoph... Cancer of Colon Cancer Skin Cancer of Cervi... Cancer, Metasta... Cancer of Laryn... Cancer of Neck Cancer of Lung Cancer of Brain... Cancer of Vulva... Cancer of Pancr... Sarcoma GIST Small-cell Lung... Adenocarcinoma ... Cancer of Prost... Cancer, Advance... Adrenal Cancer Testicular Canc... Uterine Cancer Bronchoalveolar... Cancer Unknown ... Glioblastoma Mu... Oligodendroglio... Breast Cancer Renal Cell Carc... Hepatocellular ... Cholangiocarcin... Squamous Cell C... Transitional Ce... Cancer, Other Cancer, Anal Melanoma Cancer, Bile Du... Cancer, Bladder Cancer Cords Vo... Cancers Cell Ne... Cancer Differen... Cancer, Anaplas... | 1 Month - 99 Years | SpeciCare | ||
| Far Infrared Radiation Treatment for Prostate Cancer | NCT00573820 | Prostatic Neopl... | Far Infrared Ra... | - | GAAD Medical Research Institute Inc. | |
| M9241 in Combination With Docetaxel in Adults With Metastatic Castration Sensitive and Castration Resistant Prostate Cancer | NCT04633252 | Cancer Of Prost... Prostate Neopla... | ADT Prednisone M7824 Docetaxel M9241 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer | NCT00417274 | Prostatic Cance... | Quinacrine | 18 Years - | Cleveland BioLabs | |
| Positioning and Tracking the Prostate During External Beam Radiation | NCT00123838 | Prostate Cancer | Calypso® 4D Loc... | 18 Years - | Varian, a Siemens Healthineers Company | |
| Sipuleucel-T Manufacturing Demonstration Study | NCT01477749 | Cancer of Prost... Cancer of the P... Neoplasms, Pros... Neoplasms, Pros... Prostate Cancer Prostate Neopla... Prostatic Cance... | sipuleucel-T | 18 Years - | Dendreon | |
| T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy | NCT05361798 | Cancer Of Prost... | M9241 Stereotactic Bo... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI) | NCT03031418 | Cancer of Prost... | ExoDx Prostate ... | 50 Years - | Exosome Diagnostics, Inc. | |
| A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer | NCT00134706 | Prostate Cancer | Docetaxel Carboplatin | 18 Years - | Dana-Farber Cancer Institute | |
| Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer | NCT05600400 | Prostate Cancer Cancer of Prost... Prostate Adenoc... | Stereotactic Ab... | 18 Years - | Sunnybrook Health Sciences Centre | |
| Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention | NCT06318559 | Cancer of Prost... | 3D Robot-assist... | 40 Years - 99 Years | Fondazione del Piemonte per l'Oncologia | |
| Prostatic Cancer Versus Androgen Deficiency | NCT02235142 | Cancer of Prost... | Blood sample | 18 Years - | Hopital Foch | |
| A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer | NCT00220194 | Cancer of Prost... | leuprolide acet... | 18 Years - | San Bernardino Urological Associates Medical Group Inc | |
| 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer | NCT03181867 | Prostate Neopla... Prostatic Cance... Prostate Cancer Cancer Of Prost... Metastatic Pros... | 18F-DCFPyL 18F-FDG PSMA-11 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL | NCT05588128 | Prostate Cancer Biochemically R... | 18F-DCFpyL | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors | NCT02957357 | Cancer of Prost... Cancer of the P... Prostate Cancer Prostatic Cance... | - | Alliance Foundation Trials, LLC. | ||
| Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients | NCT02614859 | Cancer of Prost... | Observation and... Metformin and B... | 18 Years - | Fox Chase Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
